Global market grows at 6.3% CAGR through 2033 as demand rises for safer, targeted chemotherapy treatments worldwide.

BANGKOK, THAILAND, February 10, 2026 / EINPresswire.com / — Researchers at Chulalongkorn University are redefining the role of Thai silk by developing silk protein into a versatile platform for ...

Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) and Sapu Bioscience today announced key advancements in its global intellectual property portfolio supporting OT-101, its proprietary TGF-β ...

The MAB brings together leading US interventional radiology experts to provide strategic clinical insights that further advance the TAMP (Trans-Arterial Micro-Perfusion) therapy platform in clinical ...

(NYSE American: OGEN) (“the “Company”) a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today previewed its targeted ...

Nanomedicine, an interdisciplinary field merging the power of nanotechnology with the intricacies of medicine, has revolutionized healthcare on a scale previously unimaginable. By manipulating ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...

As more drugs go subcutaneous, Phillips Medisize's Tony Bedford believes that high-dose biologics will become a prevalent choice for drugmakers.

The Global Liposomes Market is estimated to be valued at USD 5.34 Bn in 2025 and is expected to reach USD 10.08 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...